InvestorsObserver
×
News Home

Is it Time to Dump OPKO Health Inc (OPK) Stock After it Has Risen 13.49% in a Week?

Friday, November 17, 2023 09:50 AM | InvestorsObserver Analysts

Mentioned in this article

Is it Time to Dump OPKO Health Inc (OPK) Stock After it Has Risen 13.49% in a Week?

Overall market sentiment has been high on OPKO Health Inc (OPK) stock lately. OPK receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
OPKO Health Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on OPK!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With OPK Stock Today?

OPKO Health Inc (OPK) stock is unchanged 0% while the S&P 500 is lower by -0.07% as of 9:50 AM on Friday, Nov 17. OPK is unmoved $0.00 from the previous closing price of $1.43 on volume of 247,788 shares. Over the past year the S&P 500 is higher by 13.80% while OPK is lower by -15.88%. OPK lost -$0.28 per share in the over the last 12 months.

More About OPKO Health Inc

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a speciality active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs. Click Here to get the full Stock Report for OPKO Health Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App